...
首页> 外文期刊>Molecular medicine reports >Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease
【24h】

Rg1 exhibits neuroprotective effects by inhibiting the endoplasmic reticulum stress-mediated c-Jun N-terminal protein kinase apoptotic pathway in a rat model of Alzheimer's disease

机译:Rg1通过抑制内质网应激介导的c-Jun N端蛋白激酶凋亡途径在阿尔茨海默病模型中表现出神经保护作用

获取原文
获取原文并翻译 | 示例
           

摘要

The neuroprotective agents currently used to treat Alzheimer's disease (AD) often only target one aspect of the disease process. Therefore, identifying effective drug targets associated with the pathogenesis of AD is critical for the production of novel AD therapeutic strategies. The present study aimed to investigate the underlying mechanisms of the neuroprotective effects of Rg1 on a rat model of AD. A double transgenic beta-amyloid (A beta) precursor protein/PS1 rat model was established, which co-expressed mutations associated with AD. A beta plaques and neurofibrillary tangles (NFTs) were detected by immunohistochemistry. The detection of the protein expression levels of caspase-3 and terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) staining were used to determine the level of apoptosis in the brain tissue. The expression levels of the endoplasmic reticulum (ER) stress biomarker, glucose-regulated protein 78 (Grp78), and the mitochondrial apoptosis biomarkers, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax), were analyzed by western blotting. Furthermore, the expression of the proteins associated with the ER stress unfolded protein response (UPR) was determined, in order to examine the levels of ER stress. The mRNA expression of downstream genes of UPR were also detected by reverse transcription-polymerase chain reaction. The protein expression levels of the apoptosis-associated phosphorylated-c-Jun N-terminal protein kinase (p-JNK), caspase-12 and cAMP response element-binding transcription factor homologous protein were determined by western blotting. The results of the present study indicated that the accumulation of NFTs and A beta plaques was significantly decreased in the Rg1-treated AD rats, compared with untreated AD rats. The expression of caspase-3 and the number of TUNEL-positive cells were also significantly decreased in the Rg1-treated rats, as compared with the AD rats. Furthermore, treatment with Rg1 significantly reduced the expression of Grp78, and triggered inositol-requiring enzyme-1 (IRE-1) and phosphorylated protein kinase RNA-like ER kinase-associated ER stress. The IRE-1 UPR pathway downstream gene, tumor necrosis factor receptor-associated factor 2, was significantly decreased in rats treated with Rg1, compared with untreated AD rats. Furthermore, the activation of p-JNK was also inhibited when AD rats were treated with Rg1. In conclusion, Rg1 was shown to function as an important factor that inhibits the accumulation of NFTs and A beta via inhibition of the ER stress-mediated pathway. Blocking of this pathway was triggered by the IRE-1 and TRAF2 pathway, as a result of inhibition of the expression of p-JNK.
机译:当前用于治疗阿尔茨海默氏病(AD)的神经保护剂通常仅靶向疾病过程的一方面。因此,确定与AD发病机理相关的有效药物靶标对于产生新型AD治疗策略至关重要。本研究旨在研究Rg1对AD大鼠模型神经保护作用的潜在机制。建立了一个双转基因β-淀粉样蛋白(A beta)前体蛋白/ PS1大鼠模型,该模型共表达与AD相关的突变。通过免疫组织化学检测到β斑块和神经原纤维缠结(NFT)。检测胱天蛋白酶3的蛋白表达水平和末端脱氧核苷酸转移酶介导的dUTP缺口末端标记(TUNEL)染色来确定脑组织中的细胞凋亡水平。内质网应激生物标志物,葡萄糖调节蛋白78(Grp78)和线粒体凋亡生物标志物,B细胞淋巴瘤2(Bcl-2)和Bcl-2相关X蛋白(Bax)的表达水平,通过蛋白质印迹分析。此外,为了检查ER应激的水平,确定了与ER应激相关的蛋白质的表达未折叠的蛋白应答(UPR)。还通过逆转录-聚合酶链反应检测了UPR下游基因的mRNA表达。通过蛋白质印迹法测定凋亡相关磷酸化的c-Jun N末端蛋白激酶(p-JNK),caspase-12和cAMP反应元件结合转录因子同源蛋白的蛋白表达水平。本研究的结果表明,与未治疗的AD大鼠相比,在Rg1治疗的AD大鼠中NFT和Aβ斑块的积累显着减少。与AD大鼠相比,Rg1处理的大鼠中caspase-3的表达和TUNEL阳性细胞的数量也显着减少。此外,用Rg1处理显着降低了Grp78的表达,并触发了需要肌醇的酶-1(IRE-1)和磷酸化蛋白激酶RNA样ER激酶相关的ER应激。与未治疗的AD大鼠相比,在用Rg1治疗的大鼠中IRE-1 UPR途径下游基因,肿瘤坏死因子受体相关因子2明显降低。此外,当AD大鼠用Rg1治疗时,p-JNK的活化也被抑制。总之,Rg1被证明是通过抑制ER应激介导的途径来抑制NFT和A beta积累的重要因素。由于抑制p-JNK的表达,IRE-1和TRAF2途径触发了该途径的阻断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号